116 related articles for article (PubMed ID: 3602952)
21. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.
O'Mahony S; Anderson N; Nuki G; Ferguson A
Ann Rheum Dis; 1992 Dec; 51(12):1296-300. PubMed ID: 1485810
[TBL] [Abstract][Full Text] [Related]
22. Elisa studies in ankylosing spondylitis.
Panayi GS
Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):119-21. PubMed ID: 6652391
[TBL] [Abstract][Full Text] [Related]
23. A study of the gram-negative bacterial flora in patients with ankylosing spondylitis.
Ferraz MB; Atra E; Trabulsi LR; Goldenberg J; Sato EI
Braz J Med Biol Res; 1990; 23(1):29-36. PubMed ID: 2386846
[TBL] [Abstract][Full Text] [Related]
24. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
Ebringer A
Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis.
Mäki-Ikola O; Nissilä M; Lehtinen K; Leirisalo-Repo M; Toivanen P; Granfors K
Br J Rheumatol; 1995 May; 34(5):413-7. PubMed ID: 7788168
[TBL] [Abstract][Full Text] [Related]
26. Ankylosing spondylitis is caused by Klebsiella. Evidence from immunogenetic, microbiologic, and serologic studies.
Ebringer A
Rheum Dis Clin North Am; 1992 Feb; 18(1):105-21. PubMed ID: 1561397
[TBL] [Abstract][Full Text] [Related]
27. IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.
Vuento R; Eskola J; Leino R; Koskimies S; Viander M
Ann Rheum Dis; 1984 Apr; 43(2):186-91. PubMed ID: 6370149
[TBL] [Abstract][Full Text] [Related]
28. The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA B27 in ankylosing spondylitis patients and healthy controls.
Baines M; Ebringer A; Avakian H; Samuel D; James DC
Scand J Rheumatol; 1990; 19(5):341-9. PubMed ID: 1699267
[TBL] [Abstract][Full Text] [Related]
29. The significance of raised serum IgA in ankylosing spondylitis with IgA nephropathy.
Chou CT; Lee CF; Shieh SD; Huang HW; Ho YS
Taiwan Yi Xue Hui Za Zhi; 1984 Dec; 83(12):1232-7. PubMed ID: 6597853
[No Abstract] [Full Text] [Related]
30. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
Sullivan JS; Geczy AF
Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
[TBL] [Abstract][Full Text] [Related]
31. The relationship between Klebsiella infection and ankylosing spondylitis.
Ebringer A
Baillieres Clin Rheumatol; 1989 Aug; 3(2):321-38. PubMed ID: 2670258
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis.
Mäki-Ikola O; Lehtinen K; Toivanen P; Granfors K
Br J Rheumatol; 1995 May; 34(5):418-20. PubMed ID: 7788169
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment.
Nissilä M; Lahesmaa R; Leirisalo-Repo M; Lehtinen K; Toivanen P; Granfors K
J Rheumatol; 1994 Nov; 21(11):2082-7. PubMed ID: 7869314
[TBL] [Abstract][Full Text] [Related]
34. Raised serum IgA to common cell envelope antigens supports enterobacterial inductive contribution to pathogenesis of secondary ankylosing spondylitis.
van Bohemen CG; Weterings E; Nabbe AJ; Mulder CJ; Goei The HS; Zanen HC
Immunol Lett; 1987 Apr; 14(4):303-6. PubMed ID: 3583323
[TBL] [Abstract][Full Text] [Related]
35. [Relation between serum and salivary IgA and oral aerobic bacterial flora in patients with chronic bronchitis].
Misirligil Z; Saygun N; Yavuz S; Atakurt Y
Mikrobiyol Bul; 1985 Jan; 19(1):23-8. PubMed ID: 3872401
[TBL] [Abstract][Full Text] [Related]
36. Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.
Sanders KM; Hertzman A; Escobar MR; Littman BH
Ann Rheum Dis; 1987 Apr; 46(4):273-6. PubMed ID: 3592781
[TBL] [Abstract][Full Text] [Related]
37. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
[TBL] [Abstract][Full Text] [Related]
38. Association of gut inflammation with increased serum IgA class Klebsiella antibody concentrations in patients with axial ankylosing spondylitis (AS): implication for different aetiopathogenetic mechanisms for axial and peripheral AS?
Mäki-Ikola O; Leirisalo-Repo M; Turunen U; Granfors K
Ann Rheum Dis; 1997 Mar; 56(3):180-3. PubMed ID: 9135221
[TBL] [Abstract][Full Text] [Related]
39. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
[TBL] [Abstract][Full Text] [Related]
40. Chlamydia trachomatis serology in ankylosing spondylitis.
Csángó PA; Upsahl MT; Romberg O; Kornstad L; Sarov I
Clin Rheumatol; 1987 Sep; 6(3):384-90. PubMed ID: 3327642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]